等待开盘 12-20 09:30:00 美东时间
-0.030
-0.99%
U.S. stocks traded lower midway through trading, with the Dow Jones falling aro...
12-02 01:31
U.S. stocks traded lower this morning, with the Dow Jones falling around 200 po...
12-01 22:58
Q32 Bio shares rise after selling ADX-097 to Akebia in a deal worth up to $592 million, boosting cash runway into late 2027.
12-01 22:43
QTTB: 97% | Q32 Bio Sells Phase 2 Complement Inhibitor ADX-097 To Akebia Therapeutics For $12M Upfront Payment; Co. Eligible To receive Up To $592M In Milestones As Well As Royalties DYAI: 35% | Dyadic
12-01 20:37
Wells Fargo analyst Sarah Akers initiates coverage on Q32 Bio (NASDAQ:QTTB) with a Overweight rating and announces Price Target of $95.
2024-09-11 20:56